Premium

Alternative Insight and Premium Journalism

Latest Articles

For Members Only

Here is the Democratic Hedge Funders’ Top Choice for President

Michelle Celarier September 17, 2019

Peter Schoenfeld (Peter Foley/Bloomberg)

For Members Only

P. Schoenfeld Bets on Deals

Stephen Taub September 13, 2019

For Members Only

ValueAct Unveils Newest Target

Stephen Taub September 13, 2019

Anthony Todd, CEO of Aspect Capital (David Paul Morris/Bloomberg)

For Members Only

CTAs Surge, but Assets Slump

Stephen Taub September 12, 2019

For Members Only

These Hedge Funds Rose in a Volatile Month

Michelle Celarier September 12, 2019

For Members Only

The Little-Known Fund Driving D.E. Shaw’s Gains This Year

Stephen Taub September 11, 2019

For Members Only

Caxton Associates Gets a Boost From ESG

Stephen Taub September 10, 2019

Mark Trudeau, CEO of Mallinckrodt (Chris Goodney/Bloomberg)

For Members Only

Short Sellers Won in Mallinckrodt Mess, but Some Hedgies Held On

Michelle Celarier September 10, 2019

For Members Only

Hedge Funds Ramped Up Private Investments This Summer

Stephen Taub September 9, 2019

For Members Only

Bridgewater’s Main Strategy Sinks in August

Stephen Taub September 6, 2019

For Members Only

Are Crowded Hedge Fund Stocks Signaling Trouble Ahead?

Michelle Celarier September 5, 2019

For Members Only

Tiger Global Extends Gains

Stephen Taub September 5, 2019

Bill Ackman (Patrick T. Fallon/Bloomberg)

For Members Only

Bill Ackman’s Publicly Traded Hedge Fund Hits Its High-Water Mark

Michelle Celarier September 4, 2019

For Members Only

Equities Giveth, but Credit Taketh Away for Third Point

Stephen Taub September 4, 2019

For Members Only

Hedge Fund Favorite JUUL Rakes in Big Bucks in Latest Fund Raise

Stephen Taub September 4, 2019

For Members Only

Greenlight’s Funds Fall Sharply in August

Stephen Taub September 3, 2019

Barry Rosenstein (Andrew Harrer/Bloomberg)

For Members Only

Jana Launches Activist Campaign Against Bloomin’ Brands — Again

Stephen Taub September 3, 2019

Ken Griffin at the Delivering Alpha conference. (Heidi Gutman/CNBC)

Citadel’s Quiet Drug Fix

Steve Taub August 30, 2019

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2026 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

4.26.01 build:2026-07-21 Login